Alzheimer’s Drugs Eyed by Investors Seeking Obesity-Like Gains
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
Eli Lilly's obesity drug gets Medicare coverage for sleep apnea
Eli Lilly's obesity drug Zepbound can now be covered by government-backed Medicare insurance plans for use in sleep apnea, ...
FDA approves first ever medication for obstructive sleep apnea — here's what that means
Tirzepatide is the active ingredient in Zepbound, the FDA approved prescription medicine for Obstructive Sleep Apnea.
Neurology Advisor56m
Zepbound Approved for Obstructive Sleep Apnea in Patients With Obesity
The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.
Everyday Health13d
FDA Approves First Medication for Obstructive Sleep Apnea
By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...
The Washington Post on MSN9d
FDA approves weight-loss drug Zepbound to treat sleep apnea
The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...
Onlymyhealth10d
FDA Approves Weight-Loss Drug Zepbound For Obstructive Sleep Apnea
The U.S. Food and Drug Administration (FDA) has granted approval for Zepbound ... the interconnected challenges of obesity and sleep apnea may redefine treatment strategies for millions struggling ...
Fox News16d
FDA approves first medication for obstructive sleep apnea, which also promotes weight loss
"Today’s approval marks the first drug treatment option for certain patients ... told Fox News Digital that obesity and sleep apnea are "two of the most prevalent health conditions that affect ...
Elli Lilly's Weight Loss Drug To Be Covered In Medicare Insurance In US For THIS Treatment - All You Need To Know
Eli Lilly's obesity drug Zepbound can now be covered by government-backed Medicare insurance plans for use in sleep apnea, ...
Genetically altered fat cells in mice show promise for obesity treatment
Obese mice whose fat cells were genetically altered to produce an increased amount of the glucose-dependent insulinotropic ...
San Diego Union-Tribune10d
FDA approves weight-loss drug Zepbound to treat sleep apnea
The Food and Drug ... obesity in November 2023. Its active ingredient, tirzepatide, was previously approved as Mounjaro to treat Type 2 diabetes and became popular as an off-label weight-loss ...
As demand for weight-loss drugs rises, states grapple with Medicaid coverage
Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...